^
Association details:
Biomarker:CCL21 elevation
Cancer:Lung Adenocarcinoma
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy

Published date:
06/27/2023
Excerpt:
Patients with elevated serum levels of CCL21 benefited more from immunotherapy….Patients with a smoking history exhibited higher levels of TLS via the CCL21-dependent mechanism, serum CCL21 was identified as a reliable biomarker for predicting the efficacy of immunotherapy.
DOI:
10.1136/jitc-2023-006939